Table 2. Top 10 significantly enriched pathways at −7 d compared with −35 d.
| Pathway | DEGs with pathway annotation | Q value | Pathway ID |
| Phagosome | 41 (6.23%) | 2.87e-10 | ko04145 |
| Complement and coagulation cascades | 22 (3.34%) | 3.12e-04 | ko04610 |
| Lysosome | 23 (3.5%) | 3.12e-04 | ko04142 |
| Rheumatoid arthritis | 18 (2.74%) | 5.85e-04 | ko05323 |
| Hematopoietic cell lineage | 17 (2.58%) | 1.60e-03 | ko04640 |
| Staphylococcus aureus infection | 19 (2.89%) | 1.71e-03 | ko05150 |
| Cell adhesion molecules (CAMs) | 26 (3.95%) | 1.84e-03 | ko04514 |
| Metabolic pathways | 90 (13.68%) | 4.16e-03 | ko01100 |
| PPAR signaling pathway | 15 (2.28%) | 9.70e-03 | ko03320 |
| Bladder cancer | 9 (1.37%) | 9.70e-03 | ko05219 |